Article
Cover
RJAS Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol No: 11 Issue No: 1  pISSN: 2249-2194

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Case Report

Renuka M1*, Sajin C P2

1Department of Samhita and Siddhanta, Sushrutha Ayurvedic Medical College and Hospital, Bengaluru, Karnataka, India.

2 Department of Shareera Rachana, Sushrutha Ayurvedic Medical College and Hospital, Bengaluru, Karnataka, India.

*Corresponding author: Dr. Renuka M, Assistant Professor, Department of Samhita and Siddhanta, Sushrutha Ayurvedic Medical College and Hospital, Bengaluru, Karnataka, India. Email: drrenuayum@gmail.com Affiliated to Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka.

Received date: March 3, 2021; Accepted date: June 4, 2021; Published date: July 31, 2021 

Year: 2021, Volume: 8, Issue: 2, Page no. 44-49, DOI: 10.26715/rjas.8_2_9
Views: 3179, Downloads: 118
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. It includes a set of symptoms due to elevated androgens (male hormones) in females (Hyperandrogenemia). Signs and symptoms of PCOS include irregular or no menstrual periods, excessive bleeding during the periods, increased body and facial hair, acne, abdomen or pelvic pain, inability to conceive, and appearance of dark patches at the nape of neck, thick and velvety skin. Associated conditions include type 2 diabetes, obesity, obstructive sleep apnea, heart disease, mood disorders, and endometrial cancer. In this case study, a 22-year-old female patient presented with the complaints of pimples and increased facial hair since five years. Associated complaints were nasal block, cold and headache since three years. Clinical findings were recorded with respect to height, weight, body mass index and findings related to menstruation. She was treated with Ayurvedic purification therapy (Vamana). Remarkable changes were noted after Ayurvedic purification therapy with reduction of pimples and appearance of no new lesions. 

<p>Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. It includes a set of symptoms due to elevated androgens (male hormones) in females (Hyperandrogenemia). Signs and symptoms of PCOS include irregular or no menstrual periods, excessive bleeding during the periods, increased body and facial hair, acne, abdomen or pelvic pain, inability to conceive, and appearance of dark patches at the nape of neck, thick and velvety skin. Associated conditions include type 2 diabetes, obesity, obstructive sleep apnea, heart disease, mood disorders, and endometrial cancer. In this case study, a 22-year-old female patient presented with the complaints of pimples and increased facial hair since five years. Associated complaints were nasal block, cold and headache since three years. Clinical findings were recorded with respect to height, weight, body mass index and findings related to menstruation. She was treated with Ayurvedic purification therapy (<em>Vamana</em>). Remarkable changes were noted after Ayurvedic purification therapy with reduction of pimples and appearance of no new lesions.&nbsp;</p>
Keywords
Polycystic ovary syndrome, Hyperandrogenemia, Ayurvedic Purification Therapy, Vamana
Downloads
  • 1
    FullTextPDF
Article

Introduction

Acne vulgaris is a chronic inflammatory disease of pilosebaceous units. It is one of the most common conditions affecting adolescents. The pathogenesis of acne is multifactorial and complex.1 Seborrhea or increased sebaceous gland activity, dependent on and rogenic sex hormone is mainly of adrenal or ovarian origin.2 The polycystic ovarian syndrome (PCOS) has the highest prevalence in acne.3 It is a heterogeneous condition which is defined by the presence of two out of three criteria i.e., anovulation, polycystic ovaries, hyperandrogenism.4 In recent years, the clinical definition of PCOS has changed and includes manifestation of hyperandrogenism, chiefly acne vulgaris, hirsutism, alopecia and acanthosis; acne is a common manifestation.5

Acharya Kashyapa explained about Pushpaghni Jaataharini, where the women present with anovulatory regular cycles and increased facial hair.6 These symptoms can be related with PCOS. The present case study is an evidence which helps us to understand how an Ayurvedic purification therapy can regulate hormone levels.

Case Study

A 22 year old female patient gradually developed pimples over face, chest and upper back, with associated pain, discharge and increased facial hair since five years. Associated complaints were nasal block, cold with running nose and headache since three years. The pimples initially presented with pain, which remained for a week, later followed with the purulent discharge. After the discharge and healing, the remnant would be as a small hardened mass. The appearance of pimples was aggravated during her menstrual cycles and when she consumes oily, junk food.

General Examination

Height – 155 cm

Weight – 62 kg

Body mass index – 27

Systemic Examination

Dermatological examination – Site – face, upper part of chest, back.

Type of eruption is papulo-pustular, sometimes nodular.

Duration of lesions is 7 – 12 days (More recent is 3-4 days).

Increased facial hair 

Previous Medications

Aragwadhadi Kashayam7 - 15 ml twice a day before food for 7 days.

Thiktakam Kashayam8 - 15 ml twice a day before food for 7 days.

Sukumaram Kashayam9 - 15 ml twice a day before food for 15 days.

Shivagutika10 – 1 tab twice a day for 21 days.

Kaishora Guggulu11 - 2 tab twice a day after food for 15 days.

Eladi Gana Choorna12 - for external application with rice washed water. 

Marmani Gulika13 - for external application with egg white.

Menstrual History

Menarche – 12 years

Bleeding duration - 4-5 days

Menstrual cycle - 28-30 days

Pattern - regular

Clots - absent

Investigations

Blood routine - normal

USG abdomen reported bilateral polycystic ovaries

Criteria for Diagnosis of PCOS14

Diagnostic Assessment Based on the symptoms presented and the investigation conducted, the diagnosis was made as PCOS (Pushpagni Jataharini) (Table 1)

Therapeutic Intervention

Line of treatment adopted – Ayurvedic purification therapy (Vamana) (Table 2). Table 3 presents the assessments carried out before and after the treatment along with the follow up.

Discussion

Pushpagni Jathaharini is a condition where there is anovulatory regular cycles with increased facial hair. As the patient presented the same complaints, this case was diagnosed as Pushpagni Jataharini. Acharya Sushruta has given the description of ‘Granthi’, which is caused by vitiation of Kapha, Vata. This deranged Doshas vitiates the Rakta. Mamsa, Meda, to produce knotted swelling called ‘Granthi.’15 This can be correlated with cystic swelling in ovaries occurring in PCOS. Here, by considering Kapha with Rakta Dusti, Vyakta Sthana is Urdwabhaga, Vamana has been adopted.16 After a course of Deepana and Pachana, patient was advised Snehapana with Sukumaragritha.17

The pathogenesis of PCOS has been related to altered luteinizing hormone (LH) action, insulin resistance, and a possible inclination to hyperandrogenism.18-22 One theory states that primary insulin resistance exacerbates hyperandrogenism by suppressing synthesis of sex  hormone–binding globulin and increasing adrenal and ovarian synthesis of androgens; thereby, increasing androgen levels. These androgens further lead to irregular periods and manifestations of clinical signs and symptoms of hyperandrogenism.23 In this patient, the clinical signs of facial hair were noted, which reduced gradually over period of one month. Before the treatment, patient had thick and dark hair covering the cheeks and chin, and on the anterior part of neck. After a follow up of one month, the hair thickness reduced over cheeks and chin, and disappeared on the anterior part of neck. The patient also noticed a remarkable reduction of pimples over the cheeks by 14th day and no reoccurrence was noted on further follow up.

A polycystic ovary is defined as an ovary containing 12 or more follicles (or 25 or more follicles using new ultrasound technology), measuring 2 to 9 mm in diameter (or) an ovary that has a volume of greater than 10 mL on ultrasonography.24-26 In this case, a follow up report of USG abdomen reported normal ovaries with single or no cysts, which provided a clinical evidence of the effect of treatment.

Discharge Medicine

Varanadi Kashayam – 30 ml - 2 times a day for 15 days.

Haritaki tab – 1 tablet - 3 times a day for 15 days.

Eladi Gana Choorna – external application with rice washed water for 15 days.

The presented case study was a documentary evidence of successful management of Pushpaghni Jaatahaarini (PCOS) through Ayurvedic purification therapy (Vamana). Significant changes in clinical signs and symptoms with respect to reduction in facial hair, absence of pimples and absence of cysts in ovaries were observed. As PCOS manifests in different forms, physician should observe the symptoms in patients and correlate with the symptoms explained and accordingly the treatment can be adopted. Further research studies and trails are required to clarify the multifaceted pathophysiology of PCOS. Finally, patients with PCOS are susceptible to metabolic disorders, such as cardiovascular disease, but their impact on mortality is not clear. Therefore, more potential epidemiologic studies on the topic are necessary.

 

 

Supporting File
References
  1.  Tom WL, Barrio VR. New insight into adolescent acne. Curr Opin Pediatr 2008;20:436-40.
  2. Simpson NB, Cunliffe WJ. Disorder of the sebaceous glands. In: Burns T, Breathnach S, Cox toN, Griffiths C, editors. Rook’s Textbook of Dermatology. 7th ed. London: Blackwell Science; 2004. 43.1- 43.74. 
  3. Dekkers OM, Thio BH, Romijn JA, Smit JW. Acne vulgaris endocrine aspect. Ned Tijdschr Geneesked 2006;150:220-30. 
  4. Balen AH. Polycystic ovary syndrome and secondary amenorrhoea. In: Edmonds DK, editor. Dewhurt’s Textbook of Obstetrics & Gynecology. 7th ed. USA: Blackwell; 2007. p.377-97. 
  5. Timpatanapong P, Rojanasakul A. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. J Dermatol 1997;24:223-9. 
  6. Kashyapa Samhita. Edited by Vriddha Jivaka in Revtikalpa adhyaya,. Revised by Vatsya with Sanskrit introduction by Nepal Rajaguru Pandita Hemaraja Sharma with Vidyotini Hindi Commentary and Hindi Translation of Sanskrit introduction by Ayurvedalankar Srisatyapala Bhishag Acharya, publisher; Chaukhambha Sanskrit Sansthan, Chaukhambha publication, Reprint-2010, Revati kalpa chapter 33, Varanasi.pp 187. 
  7. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 8th edition, 2005,chapter 54,pp-891 
  8. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 8th edition, 2005,chapter 5,pp-78 
  9. Saharayoga, English translation, R Vidyanath, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 2nd edition. 2008, Kashaya Prakarana, pp-87 
  10. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chauk-hambha publication , Varanasi, 8th edition, 2005, chapter73, pp-1113 
  11. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication, Varanasi, 8th edition, 2005, chapter 27, pp-598 
  12. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication, Varanasi, 8th edition, 2005, chapter 14, pp-414 
  13. Saharayoga, English translation, R Vidyanath, Chaukhambha Sanskrit Sansthan, Chaukhambha publication, Varanasi, 2nd edition. 2008, Gutika Prakarana, pp-359 
  14. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R et al. Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013;98(12):4565–4592. 
  15. Sushruta Samhita, English translation, Edited by G.D.Singhal, Chaukhamba samskrita Pratishthan, Delhi, Part:1, 2nd edition, 2007, Chapter-11, pp.- 577 
  16. Astanga Hridaya, English translation, Edited by D Y Premchand, Chaukhamba Surabharathi Prakashana,Varanasi, First Edition,2014,chapter 18, pp-533 
  17. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 8th edition, 2005, chapter 34, pp 705 
  18.  Dafopoulos K, Venetis C, Pournaras S, Kallitsaris A, Messinis IE. Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropinreleasing hormone in women with the polycystic ovary syndrome. Fertil Steril 2009;92(4):1378– 1380. 
  19. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 2001;86(3):1318–1323. 
  20. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18(6):774–800. 
  21. Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol 2005;62(6):644–649. 
  22. Korhonen S, Hippeläinen M, Niskanen L, Vanhala M, Saarikoski S. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol 2001;184(3):289–296. 
  23. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83(5):1454–1460. 
  24. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19–25. 
  25. Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008;90(6):2269–2280. 
  26. Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2014;20(3):334–352. 
  27. Charaka Samhita by Agnivesa. Edited by Y T Acharya, Chaukhamba Orientalia, Varanasi, Reprint 2007, chapter 20, pp-115. 
  28. Kashyapa Samhita. edited by Vriddha Jivaka in Revtikalpa adhyaya, revised by Vatsya with Sanskrit introduction by Nepal Rajaguru Pandita Hemaraja Sharma with Vidyotini Hindi Commentary and Hindi Translation of Sanskrit introduction by Ayurvedalankar Srisatyapala Bhishag Acharya, publisher; Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Reprint-2010, Revati kalpa chapter 33, Varanasi.pp 187. 
  29. Jean Hailes for Women’s Health 2019 Updated September 2019, 1800 JEAN HAILES (532 642) jeanhailes.org.au/health-a-z/pcos 
  30. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 8th edition, 2005, chapter 43, pp 819. 
  31. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 8th edition, 2005, chapter 34, pp 705 
  32. Charaka Samhita by Agnivesa. Edited by Y T Acharya, Chaukhamba Orientalia, Varanasi, Reprint 2007, chapter 15, pp-94 
  33. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 8th edition, 2005,chapter 36, pp-713 34. Bhaishajya Ratanavali, Edited by B Mishra, Chaukhambha Sanskrit Sansthan, Chaukhambha publication , Varanasi, 8th edition, 2005,chapter 14, pp-414
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.